National Institute for Health and Social Care Excellence: Drug Evaluation (Internet webpage) Quebec QGdQAM, 2024). (2024). Available for purchase at: https://www.inesss.qc.ca/accueil.html
Afshari, S., Daroudi, R., Goudarzi, R., Mahboub–Ahari, A., Yaseri, M., Sari, AA, et al.: A national survey of the Iranian general population to estimate the values set in EQ-5D-5L. Quality life resolution. 32(7), 2079~2087(2023)
Google Scholar
Results Center: Research and Economic Evaluation of Health (C2H) hchngje
Drug Administration of Canada. Guidelines for the economic evaluation of health technologies: Canadian 4th edition. (2024)
NICE U: Guide to technology evaluation methods. National Institute for Health and Clinical Excellence (NICE), London. (2013)
Fernandez, J., de Boissieu, P., Galbraith, M.: Health technology assessment in Europe: organizational comparison and introduction to European regulations. la. La. Presse Médicale. (2025). https://doi.org/10.1016/j.lpm.2025.104282
Google Scholar
Weinstein, MC, Torrance, G., McGuire, A.: QALYs: the basics. The value of health. (2009). https://doi.org/10.1111/j.1524-4733.2009.00515.x
Google Scholar
Brazier, J., Ratcliffe, J., Saloman, J., Tsuchiya, A. Measuring and valuing health benefits for economic evaluation. Oxford University Press. (2017)
Brazier, J., Roberts, J., Tsuchiya, A., Busschbach, J.: Comparison of EQ‐5D and SF‐6D in seven patient groups. Health economy. 13(9), 873–884 (2004)
Google Scholar
Whitehurst, D.G., Bryan, S., Lewis, M.: A systematic review and empirical comparison of concurrent EQ-5D and SF-6D group mean scores. Med. decision. making. 31(6), E34~E44(2011)
Google Scholar
Feng, Y.-S., Kohlmann, T., Janssen, M.F., Buchholz, I.: Psychometric properties of the EQ-5D-5L: A systematic review of the literature. Quality Life Lips. 30647–673(2021)
Google Scholar
Moradi, N., Poder, T.G., Safari, H., Mojahedian, MM, Ameri, H.: Psychometric properties of the EQ-5D-5L compared with the EQ-5D-3L in Iranian cancer patients. Front. On call. 121052155 (2022)
Google Scholar
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al.: Development and preliminary testing of a new five-level version of the EQ-5D (EQ-5D-5L). Quality life resolution. 201727~1736 (2011)
Google Scholar
Mukuria, C., Rowen, D., Mulhern, B., McDool, E., Kharroubi, S., Bjorner, J.B., et al.: Short form six dimensions (SF-6D): development and evolution. Application Health. ikon. health. policy. 23(1), 19-33(2025). https://doi.org/10.1007/s40258-024-00919-8
Brazier, JE, Mulhern, BJ, Bjorner, JB, Gandek, B., Rowen, D., Alonso, J., et al.: SF-36v2: Development of a new version of the SF-6D health status classification system from SF-6Dv2. Med. care. 58(6), 557–565 (2020)
Google Scholar
Daroudi, R., Zeraati, H., Poder, T.G., Norman, R., Olyaemanesh, A., Sari, A.A., et al.: Assessing the value of the SF-6Dv2 in the Iranian capital using a discrete choice experiment across periods. Quality life resolution. 33(7), 1853~1863(2024)
Google Scholar
Shiroiwa, T., Yamamoto, Y., Murata, T., Mulhern, B., Bjorner, J., Brazier, J., et al.: Evaluation investigation of the Japanese SF-6Dv2 based on international protocols. Quality life resolution. (2024). https://doi.org/10.1007/s11136-024-03830-w
Google Scholar
Ameri, H., Poder, T.G., Evaluation: SF-6Dv2 using a discrete choice experiment in the general population of Quebec, Canada. International J. Health Policy Management. 138404(2024)
Google Scholar
Wang, L., Poder, T.G.: A systematic review of SF-6D health status assessment studies. Journal of Medical Economics. 26(1), 584–593 (2023)
Google Scholar
Zhang, A., Li, J., Mao, Z., Wang, Z., Wu, J., Luo, N., et al.: Psychometric performance of EQ-5D-5L and SF-6Dv2 in Chinese lymphoma patients. euro. J. Health Economics. (2024). https://doi.org/10.1007/s10198-024-01672-4
Google Scholar
Xie, S., Li, M., Wang, D., Hong, T., Guo, W., Wu, J.: Comparison of measurement properties of EQ-5D-5L and SF-6Dv2 among overweight and obese populations in China. Health Qualifications. Results of life. 21(1), 118(2023)
Google Scholar
Xu, RH, Luo, N., Dong, D.: Measurement characteristics of EQ-5D-3L, EQ-5D-5L, and SF-6Dv2 in patients with late-onset Pompe disease. euro. J. Health Economy. (2024). https://doi.org/10.1007/s10198-024-01682-2
Google Scholar
Xie, S., Wu, J., Chen, G.: Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 in Chinese general population. euro. J. Health Economics. 25(1), 7~19(2024)
Google Scholar
McDool, E., Mukuria, C., Brazier, J.: Comparison of SF-6Dv2 and SF-6D UK utility values in mixed patient and healthy populations. Pharmacoeconomics. 39(8), 929–940 (2021)
Google Scholar
Whitehurst, DG, Brazier, JE, Viney, R., Mulhern, BJ: SF-6Dv2: How does the new classification system affect response distributions compared to the original SF-6D? Pharmacoeconomics. 38(12), 1283~1288(2020)
Google Scholar
Xie, F., Pullenayegum, E., Gaebel, K., Bansback, N., Bryan, S., Ohinmaa, A., et al.: A set of time-exchange derived values of EQ-5D-5L for Canada. Medical . 54(1), 98–105 (2016)
Google Scholar
Poder, TG, Ameri, H.: A new SF-6Dv2 value set based on a hybrid model using SG, cTTO and DCE data. Soc. science. Med. 366117632(2025)
Google Scholar
McHorney, CA, Tarlov, AR: Individual patient monitoring in clinical practice: are available health status surveys adequate? Quality life resolution. 4(4), 293–307 (1995)
Google Scholar
Xie, S., Wang, D., Wu, J., Liu, C., Jiang, W.: Comparison of measurement properties of SF-6Dv2 and EQ-5D-5L in the Chinese Population Health Survey. Health Qualifications. Results of life. 20(1), 96(2022)
Google Scholar
Cohen, J.: Statistical power analysis for the behavioral sciences. Routledge. (2013)
Cohen, J.: A powerful primer. (2016)
Janssen, MF, Bonsel, GJ, Luo, N., Is the EQ-5D-5L better than the EQ-5D-3L? Directly compare the technology systems and value sets of seven countries. Pharmacoeconomics. 36675–697 (2018)
Google Scholar
McHugh, ML: Inter-rater reliability: the kappa statistic. Biochemical medicine. 22(3), 276–282 (2012)
Google Scholar
Bland, JM, Altman, DG: Statistical methods for assessing agreement between two clinical measurement methods. International J. Nurse. stopper. 47(8), 931-936 (2010)
Google Scholar
Brazier, JE, Yang, Y., Tsuchiya, A., Rowen, D.L.: A review of research mapping (or crossing over) nonpreference-based health measures to common preference-based measures. euro. J. Health Economics. 11(2), 215–225 (2010)
Google Scholar
Cheng, LJ, Pan, T., Chen, L.A., Cheng, JY, Mulhern, B., Devlin, N., et al.: Ceiling effects of EQ-5D-3L and 5L in general population health surveys: a systematic review and meta-analysis. Value health. 27(7), 986–997 (2024)
Google Scholar
Nahvijou, A., Safari, H., Ameri, H.: Comparing the performance of the EQ-5D-5L with two versions of the SF-6Dv2 in breast cancer patients. Health Services Outcomes Resolution. method . 20183–194(2020)
